ctrl K

Price Alert

EyePoint Pharmaceuticals ... (EYPT)

NASDAQ: EYPT · Real-Time Price · USD

11.09

0.24 (2.21%)

At close: Aug 15, 2025, 3:59 PM

11.09

0.05%

After-hours: Aug 15, 2025, 04:10 PM EDT

EyePoint Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	99.7M	281.26M	95.63M	178.59M
Short-Term Investments	271.21M	49.79M	48.93M	32.97M
Long-Term Investments	n/a	150K	150K	150K
Other Long-Term Assets	5.98M	n/a	1.36M	626K
Receivables	607K	805K	15.5M	18.35M
Inventory	2.31M	3.91M	2.89M	3.62M
Other Current Assets	1.41M	1.01M	9.86M	4.22M
Total Current Assets	383.31M	344.8M	172.81M	237.75M
Property-Plant & Equipment	29.18M	10.23M	6.04M	2.25M
Goodwill & Intangibles	n/a	n/a	n/a	22.75M
Total Long-Term Assets	35.16M	10.38M	7.55M	25.63M
Total Assets	418.46M	355.18M	180.36M	263.37M
Account Payables	11.72M	6.5M	5.92M	7.38M
Deferred Revenue	17.78M	38.59M	1.21M	1.07M
Short-Term Debt	n/a	n/a	10.47M	n/a
Other Current Liabilities	13.27M	5.54M	6.09M	5.58M
Total Current Liabilities	49.05M	63.26M	34.54M	23.66M
Long-Term Debt	n/a	n/a	29.31M	36.56M
Other Long-Term Liabilities	205K	n/a	600K	2.35M
Total Long-Term Liabilities	32.92M	25.6M	49.45M	55.33M
Total Liabilities	81.96M	88.86M	83.99M	78.99M
Total Debt	21.86M	4.91M	45.77M	38.42M
Common Stock	68K	49K	766.93M	752.64M
Retained Earnings	-873.02M	-742.15M	-671.35M	-569.1M
Comprehensive Income	1.03M	864K	786K	841K
Shareholders Equity	336.5M	266.32M	96.37M	184.38M
Total Investments	271.21M	49.94M	48.93M	32.97M